Epigenomics AG02.09.2020 / 10:32 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. […]
Year: 2020
02. September 2020
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Read more
31. August 2020
Epigenomics AG: CMS Still Actively Working on Proposed Decision Memo with Goal to Publish As Soon As Possible
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous31.08.2020 / 07:34 The issuer is solely responsible for the content of this announcement. CMS Still Actively Working on Proposed Decision Memo with Goal to Publish As Soon As Possible Berlin (Germany) and San Diego, CA (USA), August 31, 2020 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; […]
13. August 2020
Epigenomics AG presents operational highlights and reports financial results for first six months of 2020
DGAP-News: Epigenomics AG / Key word(s): Half Year Results/Quarter Results13.08.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG presents operational highlights and reports financial results for first six months of 2020 Berlin (Germany) and San Diego, CA (U.S.A.), August 13, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, […]
13. August 2020
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG13.08.2020 / 09:43 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. […]
13. August 2020
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG13.08.2020 / 10:57 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics AGGeneststraße 510829 BerlinDeutschland Notification pursuant to Sec. 43 of the German Securities Trading Act 12th August 2020 Dear Sirs, Referring to the voting rights […]
10. August 2020
New study published in the Journal of the National Cancer Institute concludes that Epi proColon(R) is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening
DGAP-News: Epigenomics AG / Key word(s): Study results/Study10.08.2020 / 08:00 The issuer is solely responsible for the content of this announcement. New study published in the Journal of the National Cancer Institute concludes that Epi proColon(R) is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening […]